Sleep Apnea

Signs of Sleep Apnea: Do You Have This Common Sleep Disorder?

Sleep apnea affects 30 million Americans — most undiagnosed. Here are the hallmark symptoms and the lesser-known signs most people miss.

By The Sleep Editorial Team·September 22, 2025·8 min read·Reviewed by Dr. James Whitfield, MD, Sleep Medicine

Signs of sleep apnea symptoms — Photograph for Sleep Editorial.

Obstructive sleep apnea affects an estimated 30 million Americans, yet the majority remain undiagnosed. The condition causes the upper airway to repeatedly collapse during sleep, producing oxygen desaturation, micro-arousals, and severely fragmented sleep architecture. The daytime consequences range from excessive fatigue to significant cardiovascular risk. Yet because sleep apnea occurs during sleep, many sufferers have no idea it is happening — and the symptoms they do notice are often attributed to stress, aging, or simply "not being a good sleeper." Recognizing the signs is the critical first step to getting evaluated and, ultimately, treated.

Key Signs of Sleep Apnea to Watch For

Loud snoring, especially with gasping, choking, or witnessed pauses in breathing
Excessive daytime sleepiness despite spending adequate time in bed
Morning headaches and dry mouth upon waking
Waking with a choking or gasping sensation
Frequent nighttime urination (nocturia) — an underrecognized apnea symptom
Difficulty concentrating, memory problems, or mood changes during the day

The hallmark symptoms of sleep apnea

The classic presentation of obstructive sleep apnea includes loud, disruptive snoring — often described by bed partners as sounding like the person is struggling to breathe — punctuated by witnessed pauses in breathing that end with a gasp or snort. This pattern reflects the core apnea cycle: the airway collapses, airflow ceases, rising carbon dioxide levels trigger an arousal response, breathing resumes, and the cycle repeats throughout the night. The person rarely remembers these arousals, but they fragment sleep architecture severely, preventing the deep, restorative stages of sleep the body requires.

The daytime consequence most specific to sleep apnea — as opposed to insomnia — is excessive daytime sleepiness rather than fatigue alone. People with sleep apnea typically fall asleep readily and quickly in passive situations: reading, watching television, sitting in meetings, or even briefly stopping at a red light. This reflects the extreme sleep debt produced by fragmented sleep architecture. In contrast, people with insomnia typically find it difficult to fall asleep even when exhausted, because of the conditioned hyperarousal that characterizes that condition. This distinction matters clinically: if you fall asleep the moment you sit still but feel unrested regardless of how many hours you spend in bed, sleep apnea is a primary concern.

Less obvious signs most people miss

Several sleep apnea symptoms are commonly missed or attributed to other causes, which is one reason the condition goes undiagnosed for an average of five to seven years after symptoms begin.

Frequent nighttime urination (nocturia) is present in a significant proportion of sleep apnea patients. Many assume waking to urinate is simply a sign of aging or a small bladder — but the mechanism here is physiological. The muscular effort of breathing against a collapsed airway produces dramatic thoracic pressure changes that trigger the release of atrial natriuretic peptide, a hormone that signals the kidneys to produce more urine. Treating sleep apnea frequently resolves nocturia without any other intervention.

Morning headaches are another commonly overlooked sign. They reflect overnight hypoxia and carbon dioxide buildup as oxygen saturation drops during apnea episodes. These headaches typically resolve within an hour or two of waking as normal breathing restores blood gas levels. If you wake most mornings with a dull headache that clears on its own, and you have other risk factors for sleep apnea, this warrants evaluation.

High blood pressure that is difficult to control despite medication is a recognized clinical marker of undiagnosed sleep apnea. The repeated oxygen desaturation episodes activate the sympathetic nervous system, raising blood pressure acutely during the night. Over time, this produces sustained hypertension that can be resistant to multiple antihypertensive medications. In fact, guidelines from major cardiology societies now recommend screening for sleep apnea in patients with resistant hypertension.

Risk factors that increase your likelihood of sleep apnea

While sleep apnea can affect anyone, certain factors substantially increase the risk. Obesity is the single strongest modifiable risk factor: excess weight, particularly around the neck and trunk, reduces airway dimensions and increases upper airway collapsibility. A neck circumference greater than 17 inches in men and 16 inches in women is associated with increased apnea risk. However, it is a common misconception that only overweight people develop sleep apnea — approximately 30% of cases occur in people with normal body weight, particularly when structural factors like a recessed jaw or enlarged tonsils are present.

Sex and age both matter. Men are two to three times more likely to have sleep apnea than premenopausal women, though this gap narrows significantly after menopause when women's rates approach men's. The risk increases with age across both sexes. Family history is also relevant: there appears to be a heritable component related to craniofacial anatomy, airway muscle tone, and the central respiratory control system.

Anatomical factors — including a deviated nasal septum, enlarged tonsils or adenoids, a small jaw (retrognathia), or a naturally narrow pharyngeal airway — can produce sleep apnea even in lean individuals. These structural contributors are why some people with sleep apnea respond better to treatments that address airway anatomy, such as oral appliances or surgical intervention, rather than or in addition to CPAP therapy.

Sleep apnea in women: a different presentation

Sleep apnea in women is substantially underdiagnosed, partly because women tend to present with different symptoms than the classic male profile. Where men more often present with loud snoring and witnessed apneas, women with sleep apnea more commonly report insomnia, fatigue, morning headaches, mood disturbances, and depression — symptoms that are frequently attributed to other causes and that lead to delays in diagnosis.

Women are also more likely to have upper airway resistance syndrome (UARS), a condition that produces significant sleep fragmentation through partial airway obstruction without the complete cessation of airflow seen in classic OSA. UARS may not be captured by standard apnea-hypopnea index scoring but produces the same daytime consequences: unrefreshing sleep, fatigue, and cognitive difficulty. A full polysomnography with careful assessment of respiratory effort is more likely to capture UARS than a simple home sleep test.

Hormonal changes across the female lifespan influence sleep apnea risk. Progesterone acts as a respiratory stimulant, which is thought to be partially protective against upper airway collapse during the reproductive years. The drop in progesterone at menopause removes this protection, which helps explain why postmenopausal women's sleep apnea risk rises to approach that of men. Pregnancy also carries elevated apnea risk, particularly in the third trimester, and gestational sleep apnea has associations with preeclampsia, gestational diabetes, and fetal outcomes — making prenatal screening increasingly important.

How sleep apnea is diagnosed

The gold standard for diagnosing sleep apnea is overnight polysomnography (PSG) in an accredited sleep laboratory. During PSG, a comprehensive array of physiological parameters is monitored simultaneously: brain electrical activity (EEG) to stage sleep, eye movements (EOG) to identify REM sleep, muscle activity (EMG), airflow at the nose and mouth, respiratory effort at the chest and abdomen, oxygen saturation, heart rate, and body position. The result is a detailed map of sleep architecture and any respiratory disturbances that occur throughout the night. The key metric produced is the apnea-hypopnea index (AHI): the number of complete or partial breathing cessations per hour of sleep. An AHI of 5–14 indicates mild apnea; 15–29 moderate; 30 or more severe.

Home sleep apnea testing (HSAT) using portable monitoring devices is now widely available and accepted for diagnosing uncomplicated obstructive sleep apnea in patients who have a high pre-test clinical probability and no significant comorbid conditions. Home tests measure fewer parameters than in-lab PSG — typically airflow, respiratory effort, and oxygen saturation — and do not stage sleep. This means the AHI from a home test is calculated against total recording time rather than actual sleep time, which tends to underestimate severity. For patients with suspected complex or central sleep apnea, severe insomnia, significant cardiac or pulmonary disease, or other complicating factors, in-lab PSG remains the appropriate first test.

When to seek evaluation

You should seek evaluation for sleep apnea if you have any of the following: habitual snoring reported by a bed partner; witnessed pauses in breathing during sleep; excessive daytime sleepiness that is not explained by insufficient sleep opportunity; waking repeatedly with choking or gasping sensations; morning headaches on most days; or unexplained blood pressure that is difficult to control. You should also consider evaluation if you have established cardiovascular disease, type 2 diabetes, treatment-resistant depression, or atrial fibrillation — all conditions with established associations with undiagnosed sleep apnea.

Your primary care physician can order a home sleep test or refer you to a sleep medicine specialist. If you prefer to pursue evaluation proactively, sleep medicine clinics at most major medical centers offer direct scheduling. Treatment for obstructive sleep apnea, most commonly continuous positive airway pressure (CPAP) therapy, is highly effective when used consistently. The majority of patients who adhere to CPAP therapy report transformative improvements in daytime energy, cognitive function, and quality of life — and significant reduction in the long-term cardiovascular and metabolic risks associated with untreated apnea.

Frequently Asked Questions

Can you have sleep apnea without snoring?

Yes — particularly with central sleep apnea, which involves failure of the brain's breathing drive rather than airway obstruction, and does not typically produce snoring. Upper airway resistance syndrome (UARS) also produces significant sleep fragmentation without classic loud snoring. Women and thinner individuals are more likely to present with atypical symptoms. If excessive daytime sleepiness is present without obvious snoring, a sleep study can still rule in or out clinically significant apnea.

What is the difference between sleep apnea fatigue and insomnia fatigue?

Sleep apnea produces excessive sleepiness — you fall asleep readily anywhere, anytime. Insomnia produces fatigue without sleepiness — you're exhausted but cannot sleep even when you want to. The Epworth Sleepiness Scale (a standardized questionnaire) helps distinguish the two. Scores above 10 suggest excessive daytime sleepiness consistent with sleep apnea; insomnia typically produces Epworth scores in the low-to-normal range despite severe subjective fatigue.

Is sleep apnea dangerous if left untreated?

Yes. Untreated obstructive sleep apnea is associated with significantly elevated risks of hypertension, coronary artery disease, heart failure, stroke, atrial fibrillation, type 2 diabetes, and metabolic syndrome. The repeated nocturnal oxygen desaturation and sympathetic nervous system activation that characterize untreated apnea impose a cumulative physiological burden on the cardiovascular and metabolic systems. Additionally, the cognitive impairment and excessive sleepiness produced by untreated sleep apnea substantially increase the risk of motor vehicle accidents.

Do I need to go to a sleep lab, or can I test at home?

Home sleep apnea tests (HSATs) are appropriate for most otherwise healthy adults with a high pre-test probability of obstructive sleep apnea. They measure airflow, respiratory effort, and oxygen saturation, and are significantly more convenient than in-lab testing. However, HSATs cannot stage sleep, may underestimate apnea severity, and are less appropriate for patients with suspected central sleep apnea, significant heart or lung disease, or complex presentations. Your physician can advise which test is appropriate for your situation.

What happens if I don't treat sleep apnea?

Without treatment, obstructive sleep apnea tends to worsen gradually, particularly with age-related changes in airway muscle tone and any weight gain over time. The cardiovascular, metabolic, and cognitive consequences accumulate. Quality of life deteriorates, relationships are affected by snoring and daytime impairment, and the risk of serious acute events — heart attack, stroke, dangerous drowsy driving — remains elevated. Treatment, most commonly CPAP, is highly effective and substantially reduces these risks.

Can children have sleep apnea?

Yes. Pediatric sleep apnea is most commonly caused by enlarged tonsils and adenoids. Signs in children include snoring, labored breathing during sleep, restless sleep, bedwetting, behavioral problems, difficulty concentrating in school, and morning headaches. Adenotonsillectomy (surgical removal of the tonsils and adenoids) is curative in the majority of pediatric cases. ADHD symptoms in children sometimes reflect undiagnosed sleep apnea and improve after treatment.

Disclosure

Sleep Editorial is an independent publication. This article reflects the editorial team's independent assessment. Sleep Editorial does not provide medical advice; consult a qualified clinician for diagnosis and treatment.